Neoantigens as potential vaccines in hepatocellular carcinoma

• Kathrin Heim,
• Maike Hofmann,
• Robert Thimme,
• Marta Ruiz,
• Pablo Sarobe,
• Sandra Hervás-Stubbs,
• Bruno Sangro,
• Luigi Buonaguro,
• Beatrice Cavalluzzo,
• Angela Mauriello,
• Maria Tagliamonte,
• David Repáraz,
• Enric Vercher,
• Diana Llopiz,
• Leyre Silva,
• Belén Aparicio,
• Josune Egea,
• Ibon Tamayo-Uria,
• Jorge García-Balduz,
• Carla Castro,
• Mercedes Iñarrairaegui,
• Charlotte Rohrer,
• Catrin Tauber

Affiliations

Kathrin Heim

Internal Medicine II, Faculty of Medicine, Freiburg University Hospital, Freiburg, Germany

Maike Hofmann

Department of Medicine II, University Hospital Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Robert Thimme

4 Department of Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectious Diseases, Medical Center, University of Freiburg, Freiburg, Germany

Marta Ruiz

1 Department of Neurosciences (DNS), University of Padova, Padova, Italy

Pablo Sarobe

1 Hepatology and Gene Therapy, CIMA, University of Navarra, Pamplona, Spain

Sandra Hervás-Stubbs

Programa de Inmunología e Inmunoterapia, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Bruno Sangro

Navarra Institute for Health Research, IdiSNA, Pamplona, Spain

Luigi Buonaguro

Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy

Beatrice Cavalluzzo

Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy

Angela Mauriello

Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy

Maria Tagliamonte

Experimental Oncology - Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, “Fondazione Pascale”- IRCCS, Naples, Italy

David Repáraz

Icahn School of Medicine at Mount Sinai, New York, NY, USA

Enric Vercher

Programa de Inmunología e Inmunoterapia, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Diana Llopiz

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Leyre Silva

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Belén Aparicio

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Josune Egea

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Ibon Tamayo-Uria

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Jorge García-Balduz

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Carla Castro

Immunology and Immunotherapy, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain

Mercedes Iñarrairaegui

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Pamplona, Spain

Charlotte Rohrer

Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Catrin Tauber

Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany